Li Richard, Vutien Philip, Omer Sabrina, Yacoub Michael, Ioannou George, Karkar Ravi, Munson Sean A, Fogarty James
University of Washington, Seattle, WA, USA.
UW Medicine and VA Puget Sound, Seattle, WA, USA.
Proc SIGCHI Conf Hum Factor Comput Syst. 2025 May;2025. doi: 10.1145/3706598.3714240. Epub 2025 Apr 25.
Chronic liver disease can lead to neurological conditions that result in coma or death. Although early detection can allow for intervention, testing is infrequent and unstandardized. Beacon is a device for at-home patient self-measurement of cognitive function via critical flicker frequency, which is the frequency at which a flickering light appears steady to an observer. This paper presents our efforts in iterating on Beacon's hardware and software to enable at-home use, then reports on an at-home deployment with 21 patients taking measurements over 6 weeks. We found that measurements were stable despite being taken at different times and in different environments. Finally, through interviews with 15 patients and 5 hepatologists, we report on participant experiences with Beacon, preferences around how CFF data should be presented, and the role of caregivers in helping patients manage their condition. Informed by our experiences with Beacon, we further discuss design implications for home health devices.
慢性肝病可导致神经疾病,进而导致昏迷或死亡。尽管早期检测能够进行干预,但检测并不频繁且未标准化。信标(Beacon)是一种供患者在家中通过临界闪烁频率自行测量认知功能的设备,临界闪烁频率是指闪烁光对观察者而言看起来稳定时的频率。本文介绍了我们为使信标设备便于在家中使用而对其硬件和软件进行迭代的工作,然后报告了一项在家中进行的部署情况,有21名患者在6周内进行了测量。我们发现,尽管测量是在不同时间和不同环境下进行的,但测量结果是稳定的。最后,通过对15名患者和5名肝病专家的访谈,我们报告了参与者使用信标的体验、对临界闪烁频率(CFF)数据呈现方式的偏好,以及护理人员在帮助患者管理病情方面的作用。基于我们使用信标的经验,我们进一步讨论了家庭健康设备的设计含义。